Livzon Pharmaceutical Group, Inc. (LVZPF)
3.799
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Livzon Pharmaceutical Group EPS Diluted (Quarterly) : 0.0588 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0588 |
| March 31, 2026 | 0.0939 |
| December 31, 2025 | 0.0428 |
| September 30, 2025 | 0.075 |
| June 30, 2025 | 0.1006 |
| March 31, 2025 | 0.0976 |
| December 31, 2024 | 0.0598 |
| September 30, 2024 | 0.0762 |
| June 30, 2024 | 0.0841 |
| March 31, 2024 | 0.0913 |
| December 31, 2023 | 0.0527 |
| September 30, 2023 | 0.0692 |
| June 30, 2023 | 0.0844 |
| March 31, 2023 | 0.0911 |
| December 31, 2022 | 0.0606 |
| September 30, 2022 | 0.0763 |
| June 30, 2022 | 0.0751 |
| March 31, 2022 | 0.0932 |
| December 31, 2021 | 0.0539 |
| September 30, 2021 | 0.0644 |
| June 30, 2021 | 0.0898 |
| March 31, 2021 | 0.0849 |
| December 31, 2020 | 0.0472 |
| September 30, 2020 | 0.0644 |
| June 30, 2020 | 0.091 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0612 |
| December 31, 2019 | 0.0399 |
| September 30, 2019 | 0.0459 |
| June 30, 2019 | 0.0543 |
| March 31, 2019 | 0.0623 |
| December 31, 2018 | 0.022 |
| September 30, 2018 | 0.0482 |
| June 30, 2018 | 0.048 |
| March 31, 2018 | 0.0586 |
| December 31, 2017 | 0.0295 |
| September 30, 2017 | 0.60 |
| June 30, 2017 | 0.0357 |
| March 31, 2017 | 0.0427 |
| December 31, 2016 | 0.0267 |
| September 30, 2016 | 0.028 |
| June 30, 2016 | 0.0314 |
| March 31, 2016 | 0.0404 |
| December 31, 2015 | 0.0228 |
| September 30, 2015 | 0.0282 |
| June 30, 2015 | 0.0293 |
| March 31, 2015 | 0.0337 |
| December 31, 2014 | 0.0177 |
| September 30, 2014 | 0.0256 |
| June 30, 2014 | 0.0281 |
| March 31, 2014 | 0.0275 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 58.31M |
| Revenue (Quarterly) | 312.73M |
| Total Expenses (Quarterly) | 260.53M |
| Enterprise Value | 2.971B |
| Gross Profit Margin (Quarterly) | 52.93% |
| Profit Margin (Quarterly) | 18.65% |
| Earnings Yield | 7.12% |
| Operating Earnings Yield | 9.23% |
| Normalized Earnings Yield | 7.026 |